We have been successful in obtaining research funding from several prestigious sources to fund our work relating to the use of peptide nanomaterials for drug delivery and biomaterial applications.
Most notably from the EPSRC (EP/S031561/1) Wellcome Trust (07618/Z/17/Z) and Royal Society Research Grant (RG150171) and International Exchanges award in collaboration with Trinity College Dublin (IE1609880).
We will continue to pursue investment in order to advance the development of our exciting technologies.
MORE RESEARCH & FUNDING
Self-assembled peptides are composed of amino acid building blocks which assemble, via intermolecular interactions into nanomaterial structures, in response to physiological stimuli including: pH, temperature, ionic strength, and the presence of specific enzymes. By modifying the amino acid sequence we can control whether these peptides assemble into hydrogels composed of nanofibers or peptide nanotube structures. […]
BIOMATERIALS AND MEDICAL DEVICES
Healthcare associated infections (HAIs) are estimated to cost the NHS £1 billion per annum, of these medical device infections account for half of all cases. Intravascular catheters are commonly inserted in hospital and outpatient settings to administer drugs, provide nutritional support and monitor patients. They include peripheral and central venous catheters, arterial catheters and haemodialysis […]
Chronic wounds are amongst the most debilitating and burdensome healthcare disorders impacting society with a UK incidence of 575,600 patients annually costing the NHS up to £3.1billion per year. The scale of this problem will escalate due to an increase in factors that contribute to chronic wounds, for example increased life expectancy (a more elderly […]